
Evolution Devices is a company focused on restoring and rehabilitating mobility through wearable technology. Their primary product, EvoWalk, is a non-invasive functional electrical stimulation (FES) device that uses AI and machine learning to adapt to a user's gait, providing personalized therapeutic care for walking impairments caused by neurological conditions such as stroke and multiple sclerosis. The company also offers EvoVision, a markerless motion capture system for gait analysis. Founded by UC Berkeley alumni Pierluigi Mantovani and Juan M. Rodriguez, the company was motivated by a personal need to improve mobility solutions. EvoWalk has received FDA 510(k) clearance. They have achieved over 14.7 million steps with their device and are trusted by gait labs at universities, rehab clinics, and children's hospitals.

Evolution Devices is a company focused on restoring and rehabilitating mobility through wearable technology. Their primary product, EvoWalk, is a non-invasive functional electrical stimulation (FES) device that uses AI and machine learning to adapt to a user's gait, providing personalized therapeutic care for walking impairments caused by neurological conditions such as stroke and multiple sclerosis. The company also offers EvoVision, a markerless motion capture system for gait analysis. Founded by UC Berkeley alumni Pierluigi Mantovani and Juan M. Rodriguez, the company was motivated by a personal need to improve mobility solutions. EvoWalk has received FDA 510(k) clearance. They have achieved over 14.7 million steps with their device and are trusted by gait labs at universities, rehab clinics, and children's hospitals.
Headquarters: Oakland / San Francisco, CA
Flagship product: EvoWalk — FDA 510(k)-cleared AI-enabled wearable FES for foot drop
Founders: Pierluigi Mantovani (Co-founder & CEO), Juan M. Rodriguez (Co-founder & CTO)
Team size: ~9 employees
Recent funding event: Grant closed Jun 1, 2022
Mobility rehabilitation for neurological conditions causing foot drop (e.g., stroke, multiple sclerosis).
2017
Medical devices / Digital health
Most recent funding event listed as a grant on Jun 1, 2022.
“Received grant funding and support from organizations that include the National Science Foundation and Alchemist Accelerator.”